CN111297762A - 一种眼霜及其制备方法 - Google Patents
一种眼霜及其制备方法 Download PDFInfo
- Publication number
- CN111297762A CN111297762A CN202010287185.4A CN202010287185A CN111297762A CN 111297762 A CN111297762 A CN 111297762A CN 202010287185 A CN202010287185 A CN 202010287185A CN 111297762 A CN111297762 A CN 111297762A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- peg
- eye cream
- whitening composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 56
- 230000002087 whitening effect Effects 0.000 claims abstract description 43
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 38
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 33
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 244000153955 Reynoutria sachalinensis Species 0.000 claims abstract description 24
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims abstract description 24
- 229940116257 pepper extract Drugs 0.000 claims abstract description 24
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 21
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 21
- 239000011570 nicotinamide Substances 0.000 claims abstract description 21
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 16
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 16
- FSEJJKIPRNUIFL-UHFFFAOYSA-N [2,2-bis(hydroxymethyl)-3-octadecanoyloxypropyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCCCCCCCCCCCCC FSEJJKIPRNUIFL-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960001631 carbomer Drugs 0.000 claims abstract description 16
- 229940100460 peg-100 stearate Drugs 0.000 claims abstract description 16
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 15
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 11
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940075529 glyceryl stearate Drugs 0.000 claims abstract description 11
- 229940057910 shea butter Drugs 0.000 claims abstract description 11
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims abstract description 5
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims abstract description 5
- NMAQSOQOKDHXGW-NOVBDOAMSA-N C(CCCCCCCCCCCCCCCCC)(=O)O.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)O.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO NMAQSOQOKDHXGW-NOVBDOAMSA-N 0.000 claims abstract 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 51
- 239000004359 castor oil Substances 0.000 claims description 29
- 235000019438 castor oil Nutrition 0.000 claims description 29
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 25
- 239000011259 mixed solution Substances 0.000 claims description 24
- 239000003921 oil Substances 0.000 claims description 18
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 17
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 13
- 238000004945 emulsification Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 8
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000005086 pumping Methods 0.000 claims description 6
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 3
- 229940035437 1,3-propanediol Drugs 0.000 claims description 3
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 3
- 238000002474 experimental method Methods 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 5
- 230000037303 wrinkles Effects 0.000 abstract description 4
- 238000005562 fading Methods 0.000 abstract 1
- -1 decyl glycol Chemical compound 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 17
- 238000002835 absorbance Methods 0.000 description 15
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 11
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 11
- 229960005323 phenoxyethanol Drugs 0.000 description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- 210000000744 eyelid Anatomy 0.000 description 9
- 238000005303 weighing Methods 0.000 description 9
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- 240000001341 Reynoutria japonica Species 0.000 description 6
- 235000018167 Reynoutria japonica Nutrition 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 6
- BOSXZNXZBFCZQM-UHFFFAOYSA-N 2-(2-hydroxypropoxy)propan-1-ol Chemical compound CC(O)COC(C)CO.CC(O)COC(C)CO BOSXZNXZBFCZQM-UHFFFAOYSA-N 0.000 description 5
- 241001440269 Cutina Species 0.000 description 5
- 229940049638 carbomer homopolymer type c Drugs 0.000 description 5
- 229940043234 carbomer-940 Drugs 0.000 description 5
- INSRQEMEVAMETL-UHFFFAOYSA-N decane-1,1-diol Chemical compound CCCCCCCCCC(O)O INSRQEMEVAMETL-UHFFFAOYSA-N 0.000 description 5
- XGZRAKBCYZIBKP-UHFFFAOYSA-L disodium;dihydroxide Chemical compound [OH-].[OH-].[Na+].[Na+] XGZRAKBCYZIBKP-UHFFFAOYSA-L 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 230000036564 melanin content Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 239000001054 red pigment Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 235000003143 Panax notoginseng Nutrition 0.000 description 3
- 241000180649 Panax notoginseng Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 2
- PETRWTHZSKVLRE-UHFFFAOYSA-N 2-Methoxy-4-methylphenol Chemical compound COC1=CC(C)=CC=C1O PETRWTHZSKVLRE-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229940082044 2,3-dihydroxybenzoic acid Drugs 0.000 description 1
- DBFHTTOOJDMDTI-KCMGSBMCSA-N C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO DBFHTTOOJDMDTI-KCMGSBMCSA-N 0.000 description 1
- 240000002989 Euphorbia neriifolia Species 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- YRVCHYUHISNKSG-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO.OCCCO YRVCHYUHISNKSG-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- STWNGMSGPBZFMX-UHFFFAOYSA-N pyridine-3-carboxamide Chemical compound NC(=O)C1=CC=CN=C1.NC(=O)C1=CC=CN=C1 STWNGMSGPBZFMX-UHFFFAOYSA-N 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
名称 | 标准中文名称 | 供应商 |
烟酰胺 | 烟酰胺 | DSM |
虎杖提取物 | 水、丁二醇、虎杖(POLYGONUM CUSPIDATUM)提取物 | 上海珈叶 |
胡椒提取物 | 胡椒(PIPER NIGRUM)提取物 | 北京信诺久恒 |
1,3-丙二醇 | 1,3-丙二醇 | 杜邦 |
PEG-40 氢化蓖麻油 | PEG-40 氢化蓖麻油 | BASF |
卡波940 | 卡波姆 | Lubrizol |
双丙甘醇 | 双丙甘醇 | 陶氏化学 |
TEGOCARE PS | 甲基葡糖倍半硬脂酸酯 | 赢创 |
ARLACEL 165 | 甘油硬脂酸酯/PEG-100 硬脂酸酯 | CRODA |
Cutina PES | 季戊四醇二硬脂酸酯 | BASF |
KF-995 | 环五聚二甲基硅氧烷 | 徽之克 |
乳木果油 | 牛油果树(BUTYROSPERMUM PARKII)果脂 | BASF |
EDTA 二钠 | EDTA 二钠 | AkzoNobel |
氢氧化钠 | 氢氧化钠 | 北京化工厂 |
Microcare®PHDG | 苯氧乙醇/辛甘醇/癸二醇 | THOR |
三七提取物 | 水、丁二醇、三七(PANAX NOTOGINSENG)根提取物 | 上海珈叶 |
VC乙基醚 | 3-o-乙基抗坏血酸 | 北京信诺久恒 |
名称 | 标准中文名称 | 用量(wt%) |
实施例1制备美白组合物 | —— | 0.5 |
双丙甘醇 | 双丙甘醇 | 1 |
卡波940 | 卡波姆 | 0.1 |
EDTA 二钠 | EDTA 二钠 | 0.01 |
TEGOCARE PS | 甲基葡糖倍半硬脂酸酯 | 0.1 |
ARLACEL 165 | 甘油硬脂酸酯/PEG-100 硬脂酸酯 | 5 |
Cutina PES | 季戊四醇二硬脂酸酯 | 2 |
KF-995 | 环五聚二甲基硅氧烷 | 5 |
乳木果油 | 牛油果树(BUTYROSPERMUM PARKII)果脂 | 5 |
氢氧化钠 | 氢氧化钠 | 0.01 |
Microcare®PHDG | 苯氧乙醇/辛甘醇/癸二醇 | 0.4 |
水 | 水 | 余量 |
名称 | 标准中文名称 | 用量(wt%) |
实施例2制备美白组合物 | —— | 6 |
双丙甘醇 | 双丙甘醇 | 2.5 |
卡波940 | 卡波姆 | 0.4 |
EDTA 二钠 | EDTA 二钠 | 0.01 |
TEGOCARE PS | 甲基葡糖倍半硬脂酸酯 | 3.5 |
ARLACEL 165 | 甘油硬脂酸酯/PEG-100 硬脂酸酯 | 2.5 |
Cutina PES | 季戊四醇二硬脂酸酯 | 1.2 |
KF-995 | 环五聚二甲基硅氧烷 | 1.5 |
乳木果油 | 牛油果树(BUTYROSPERMUM PARKII)果脂 | 1.5 |
氢氧化钠 | 氢氧化钠 | 0.01 |
Microcare®PHDG | 苯氧乙醇/辛甘醇/癸二醇 | 1.0 |
水 | 水 | 余量 |
名称 | 标准中文名称 | 用量(wt%) |
实施例3制备美白组合物 | —— | 20 |
双丙甘醇 | 双丙甘醇 | 5 |
卡波940 | 卡波姆 | 0.5 |
EDTA 二钠 | EDTA 二钠 | 0.1 |
TEGOCARE PS | 甲基葡糖倍半硬脂酸酯 | 5 |
ARLACEL 165 | 甘油硬脂酸酯/PEG-100 硬脂酸酯 | 0.1 |
Cutina PES | 季戊四醇二硬脂酸酯 | 0.1 |
KF-995 | 环五聚二甲基硅氧烷 | 1 |
乳木果油 | 牛油果树(BUTYROSPERMUM PARKII)果脂 | 1 |
氢氧化钠 | 氢氧化钠 | 0.1 |
Microcare®PHDG | 苯氧乙醇/辛甘醇/癸二醇 | 1.0 |
水 | 水 | 71 |
名称 | 标准中文名称 | 用量(wt%) |
实施例4制备美白组合物 | —— | 15 |
双丙甘醇 | 双丙甘醇 | 3 |
卡波940 | 卡波姆 | 0.2 |
EDTA 二钠 | EDTA 二钠 | 0.03 |
TEGOCARE PS | 甲基葡糖倍半硬脂酸酯 | 0.5 |
ARLACEL 165 | 甘油硬脂酸酯/PEG-100 硬脂酸酯 | 2 |
Cutina PES | 季戊四醇二硬脂酸酯 | 1 |
KF-995 | 环五聚二甲基硅氧烷 | 2 |
乳木果油 | 牛油果树(BUTYROSPERMUM PARKII)果脂 | 4 |
氢氧化钠 | 氢氧化钠 | 0.04 |
Microcare®PHDG | 苯氧乙醇/辛甘醇/癸二醇 | 0.5 |
水 | 水 | 71.73 |
黑色素含量平均值 | 实施例5 | 实施例6 | 实施例7 | 实施例8 | 对比例6 |
第0周 | 151 | 144 | 137 | 140 | 135 |
第2周 | 146 | 140 | 132 | 128 | 133 |
第6周 | 125 | 126 | 109 | 103 | 121 |
黑色素含量变化率 | 实施例5 | 实施例6 | 实施例7 | 实施例8 | 对比例6 |
第2周 | -3.31% | -2.78% | -3.65% | -8.57% | -1.48% |
第6周 | -17.22% | -12.50% | -20.44% | -26.43% | -10.37% |
红色素含量平均值 | 实施例5 | 实施例6 | 实施例7 | 实施例8 | 对比例6 |
第0周 | 235 | 238 | 229 | 238 | 240 |
第2周 | 234 | 239 | 222 | 231 | 238 |
第6周 | 225 | 232 | 214 | 206 | 237 |
红色素含量变化率 | 实施例5 | 实施例6 | 实施例7 | 实施例8 | 对比例6 |
第2周 | -0.43% | 0.42% | -3.06% | -2.94% | -0.83% |
第6周 | -4.26% | -2.52% | -6.55% | -13.45% | -1.25% |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010287185.4A CN111297762A (zh) | 2020-04-13 | 2020-04-13 | 一种眼霜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010287185.4A CN111297762A (zh) | 2020-04-13 | 2020-04-13 | 一种眼霜及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111297762A true CN111297762A (zh) | 2020-06-19 |
Family
ID=71162740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010287185.4A Pending CN111297762A (zh) | 2020-04-13 | 2020-04-13 | 一种眼霜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111297762A (zh) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040219124A1 (en) * | 2003-05-01 | 2004-11-04 | Gupta Shyam K. | Cosmetic and Pharmaceutical Masks Based on Ion-Pair Delivery System |
US20050271608A1 (en) * | 2004-06-05 | 2005-12-08 | Gupta Shyam K | Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives |
KR20110075743A (ko) * | 2009-12-29 | 2011-07-06 | (주)더페이스샵 | 미백 복합물을 함유하는 피부미백용 화장료 조성물 |
CN105147590A (zh) * | 2015-10-19 | 2015-12-16 | 广州科玛生物科技有限公司 | 一种抗皱眼霜及其制备方法 |
CN105596222A (zh) * | 2016-01-25 | 2016-05-25 | 广东工业大学 | 一种精准修复与护理面膜的制备方法 |
CN106377485A (zh) * | 2016-12-12 | 2017-02-08 | 珍尔姿(广州)化妆品有限公司 | 一种具有美白和改善皱纹的功效性眼部精华 |
CN106420498A (zh) * | 2016-11-27 | 2017-02-22 | 珍尔姿(广州)化妆品有限公司 | 一种改善眼部肌肤暗沉的修护眼霜 |
KR20170122677A (ko) * | 2016-04-27 | 2017-11-06 | 주식회사 엘지생활건강 | 폴리다틴 또는 이의 약학적으로 허용 가능한 염의 광 안정화용 조성물 |
US20180207077A1 (en) * | 2017-01-26 | 2018-07-26 | L'oreal | Microemulsion compositions comprising polydatin and method of use |
CN109223633A (zh) * | 2018-09-14 | 2019-01-18 | 孟祥文 | 一种眼部护理霜及其制备方法 |
CN109464307A (zh) * | 2018-10-31 | 2019-03-15 | 成都珂萝瑞诗化妆品有限公司 | 一种弹力紧致眼霜及其制备方法 |
-
2020
- 2020-04-13 CN CN202010287185.4A patent/CN111297762A/zh active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040219124A1 (en) * | 2003-05-01 | 2004-11-04 | Gupta Shyam K. | Cosmetic and Pharmaceutical Masks Based on Ion-Pair Delivery System |
US20050271608A1 (en) * | 2004-06-05 | 2005-12-08 | Gupta Shyam K | Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives |
KR20110075743A (ko) * | 2009-12-29 | 2011-07-06 | (주)더페이스샵 | 미백 복합물을 함유하는 피부미백용 화장료 조성물 |
CN105147590A (zh) * | 2015-10-19 | 2015-12-16 | 广州科玛生物科技有限公司 | 一种抗皱眼霜及其制备方法 |
CN105596222A (zh) * | 2016-01-25 | 2016-05-25 | 广东工业大学 | 一种精准修复与护理面膜的制备方法 |
KR20170122677A (ko) * | 2016-04-27 | 2017-11-06 | 주식회사 엘지생활건강 | 폴리다틴 또는 이의 약학적으로 허용 가능한 염의 광 안정화용 조성물 |
CN106420498A (zh) * | 2016-11-27 | 2017-02-22 | 珍尔姿(广州)化妆品有限公司 | 一种改善眼部肌肤暗沉的修护眼霜 |
CN106377485A (zh) * | 2016-12-12 | 2017-02-08 | 珍尔姿(广州)化妆品有限公司 | 一种具有美白和改善皱纹的功效性眼部精华 |
US20180207077A1 (en) * | 2017-01-26 | 2018-07-26 | L'oreal | Microemulsion compositions comprising polydatin and method of use |
CN109223633A (zh) * | 2018-09-14 | 2019-01-18 | 孟祥文 | 一种眼部护理霜及其制备方法 |
CN109464307A (zh) * | 2018-10-31 | 2019-03-15 | 成都珂萝瑞诗化妆品有限公司 | 一种弹力紧致眼霜及其制备方法 |
Non-Patent Citations (2)
Title |
---|
王建新: "《化妆品植物原料大全》", 30 June 2012, 中国纺织出版社, pages: 140 * |
珠曼: "珠曼护肤系列之--赋活精华液", pages 4, Retrieved from the Internet <URL:https://mp.weixin.qq.com/s?src=11×tamp=1705457822&ver=5023&signature=05-3tt*bfca7pRXy5QEu-TsE-D9cf2cDqdvQtV661KlYXVnjFtmZ3iOVhyooBczsd0oa0TW2GXRJFvKhBJgQo8xNA8pFcDjafz21jpWiqeEF1TUCQSyuMqgkHvgwpZ3N&new=1> * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10463605B2 (en) | Camellia extract, its preparation method, and its use | |
JP2014024766A (ja) | 不安定染料を安定的に配合した肌、毛髪の着色を目的とした外用剤 | |
CN106265117A (zh) | 光保护性组合物 | |
CN110339076B (zh) | 一种具有广谱光防护作用的防晒组合物及其制备方法与应用 | |
CN110314118A (zh) | 具有抗衰老、修复功效的组合物及其制备方法和应用 | |
US20230157935A1 (en) | Gadusol-containing sunscreen formulations | |
CN105560127B (zh) | 一种天然色素cc霜及其制备方法 | |
CN109908004B (zh) | 一种多重乳液防晒化妆品及其制备方法 | |
US20160317420A1 (en) | Method of improving the appearance of skin and compositions therefor | |
CN110575410A (zh) | 含防护蓝光成分的化妆品 | |
EP2139459A1 (fr) | Composition dermatologique pour la prevention et/ou le traitement de la rosacee, de la couperose ou des peaux qui presentent des rougeurs diffuses ou des petits vaisseaux dilates | |
CN109394640A (zh) | 一种酵素护肤组合物及其应用 | |
DE60131422T2 (de) | Zubereitung enthaltend vitamin-c-bestandteil und pigment | |
EP3043770B1 (en) | Cosmetic compositions containing a combination of natural active ingredients | |
CN108938508A (zh) | 一种具有防晒增效作用的无花果果实提取物及其用途 | |
CN111297762A (zh) | 一种眼霜及其制备方法 | |
KR101050237B1 (ko) | 소나무 수피 추출물을 이용한 기능성 화장품 조성물 | |
CN113520902A (zh) | 一种美白乳液及其制备方法 | |
CN111265423A (zh) | 一种具有美白功效的精华液及其制备方法 | |
JP4643789B2 (ja) | 皮膚外用剤 | |
CN113520927A (zh) | 一种具有美白功效的护肤水及其制备方法 | |
CN107334691A (zh) | 一种美白化妆品组合物 | |
CN111228188A (zh) | 一种具有美白功效的面膜及其制备方法 | |
CN115177565A (zh) | 一种美白亮肤组合物及其在化妆品中的应用 | |
CN104411368A (zh) | 光防护性个人护理组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240208 Address after: Room A2-06-05, Building 1, No. 338 Huilongguan East Street, Changping District, Beijing, 100194 Applicant after: BEIJING GUOJI ZHONGFANG TRADITIONAL CHINESE MEDICINE Research Institute Country or region after: China Address before: 1105-2, floor 10, building a, yard 72, North West Third Ring Road, Haidian District, Beijing 100048 Applicant before: Beijing youyue Baishi Technology Development Co.,Ltd. Country or region before: China |